Apoptosis in thyroid neoplasms: relationship with p53 and bcl-2 expression

Area of Science:

• Oncology
• Cell Biology
• Molecular Pathology

Background:

• Cellular gain and loss are concurrent processes in tumor development.
• Apoptosis, or programmed cell death, is a critical factor influencing tumor growth and aggressiveness.
• Understanding the regulators of apoptosis is key to comprehending tumor behavior.

Purpose of the Study:

• To investigate the relationship between apoptosis and tumor differentiation in thyroid neoplasms.
• To examine the association of apoptosis with the expression of mutated p53 and bcl-2 in thyroid tumors.
• To elucidate the role of apoptosis in the pathogenesis of various thyroid neoplasms.

Main Methods:

• Semiquantitative analysis of apoptosis using a DNA end ligase method in 53 thyroid tumors and 10 multinodular goiters.
• Quantitative immunostaining for bcl-2 and p53, key regulators of apoptosis.
• Statistical correlation analysis to determine relationships between apoptosis, bcl-2, and p53 expression.

Main Results:

• No apoptosis was detected in normal thyroid tissues, goiters, or follicular adenomas, which were bcl-2 positive.
• Anaplastic and insular carcinomas showed increased apoptosis with high p53 and low bcl-2 expression.
• Papillary carcinomas exhibited variable apoptosis rates; 41% showed no apoptosis (p53 negative, bcl-2 positive), 44% had low apoptosis (variable bcl-2, negative p53), and 15% had high apoptosis (p53 negative, bcl-2 negative).
• A significant correlation was found between apoptosis and bcl-2 expression (P < 0.001), but not with p53.

Conclusions:

• Bcl-2 expression in thyroid neoplasms is significantly related to apoptosis.
• Mutated p53 expression is associated with high-grade thyroid tumors but may not be universally involved in thyroid apoptotic pathways.
• These findings highlight the differential roles of bcl-2 and p53 in regulating apoptosis across various thyroid tumor types.